Search Results - "LIANIDOU, Evi"

Detection and relevance of epigenetic markers on ctDNA: recent advances and future outlook by Lianidou, Evi

“…Liquid biopsy, a minimally invasive approach, is a highly powerful clinical tool for the real‐time follow‐up of cancer and overcomes many limitations of tissue…”
Get full text

Liquid biopsies by Lianidou, Evi, Pantel, Klaus

“…Liquid biopsy is based on minimally invasive blood tests and has a high potential to significantly change the therapeutic strategy in cancer patients,…”
Get full text

Circulating Tumor Cells in Breast Cancer: Detection Systems, Molecular Characterization, and Future Challenges by LIANIDOU, Evi S, MARKOU, Athina

“…Circulating tumor cell (CTC) analysis is a promising new diagnostic field for estimating the risk for metastatic relapse and metastatic progression in patients…”
Get full text

Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes by Giannopoulou, Lydia, Zavridou, Martha, Kasimir-Bauer, Sabine, Lianidou, Evi S.

“…Ovarian cancer still remains the most lethal female cancer, since in most cases it is diagnosed at an advanced stage. Usually after completion of primary…”
Get full text

Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA by Giannopoulou, Lydia, Kasimir-Bauer, Sabine, Lianidou, Evi S

“…Ovarian cancer remains the most lethal disease among gynecological malignancies despite the plethora of research studies during the last decades. The majority…”
Get more information

Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers by Panagopoulou, Maria, Karaglani, Makrina, Balgkouranidou, Ioanna, Biziota, Eirini, Koukaki, Triantafillia, Karamitrousis, Evaggelos, Nena, Evangelia, Tsamardinos, Ioannis, Kolios, George, Lianidou, Evi, Kakolyris, Stylianos, Chatzaki, Ekaterini

“…Blood circulating cell-free DNA (ccfDNA) is a suggested biosource of valuable clinical information for cancer, meeting the need for a minimally-invasive…”
Get full text

The Role of CTCs as Tumor Biomarkers by Lianidou, Evi S, Markou, Athina, Strati, Areti

“…Detection of Circulating Tumor Cells (CTCs) in peripheral blood can serve as a "liquid biopsy" approach and as a source of valuable tumor markers. CTCs are…”
Get more information

Gene expression profiling and DNA methylation analyses of CTCs by Lianidou, Evi S.

“…A variety of molecular assays have been developed for CTCs detection and molecular characterization. Molecular assays are based on the nucleic acid analysis in…”
Get full text

Prognostic Significance of TWIST1 , CD24 , CD44 , and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients by Strati, Areti, Nikolaou, Michail, Georgoulias, Vassilis, Lianidou, Evi S

“…(1) Background: The aim of the study was to evaluate the prognostic significance of EMT-associated ( and stem-cell (SC) transcript ( , , ) quantification in…”
Get full text

Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability by Sourvinou, Ioanna S, Markou, Athina, Lianidou, Evi S

“…Circulating miRNAs are intensively evaluated as promising blood-based biomarkers. This growing interest in developing assays for circulating miRNAs…”
Get full text

Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients by Ntzifa, Aliki, Strati, Areti, Kallergi, Galatea, Kotsakis, Athanasios, Georgoulias, Vassilis, Lianidou, Evi

“…Liquid biopsy is a tool to unveil resistance mechanisms in NSCLC. We studied changes in gene expression in CTC-enriched fractions of EGFR-mutant NSCLC patients…”
Get full text

SOX17 promoter methylation in circulating tumor cells and matched cell-free DNA isolated from plasma of patients with breast cancer by Chimonidou, Maria, Strati, Areti, Malamos, Nikos, Georgoulias, Vasilis, Lianidou, Evi S

“…Detection of circulating tumor cells (CTCs) and cell-free DNA (cfDNA) in the peripheral blood of patients with solid tumors has been widely studied for the…”
Get full text

SARS-CoV-2 wastewater surveillance data can predict hospitalizations and ICU admissions by Galani, Aikaterini, Aalizadeh, Reza, Kostakis, Marios, Markou, Athina, Alygizakis, Nikiforos, Lytras, Theodore, Adamopoulos, Panagiotis G., Peccia, Jordan, Thompson, David C., Kontou, Aikaterini, Karagiannidis, Apostolos, Lianidou, Evi S., Avgeris, Margaritis, Paraskevis, Dimitrios, Tsiodras, Sotirios, Scorilas, Andreas, Vasiliou, Vasilis, Dimopoulos, Meletios-Athanasios, Thomaidis, Nikolaos S.

“…We measured SARS-CoV-2 RNA load in raw wastewater in Attica, Greece, by RT-qPCR for the environmental surveillance of COVID-19 for 6 months. The lag between…”
Get full text

ESR1 Methylation: A Liquid Biopsy-Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment by Mastoraki, Sophia, Strati, Areti, Tzanikou, Eleni, Chimonidou, Maria, Politaki, Eleni, Voutsina, Alexandra, Psyrri, Amanda, Georgoulias, Vassilis, Lianidou, Evi

“…Liquid biopsy provides real-time monitoring of tumor evolution and response to therapy through analysis of circulating tumor cells (CTCs) and…”
Get full text

Circulating tumor cells as promising novel biomarkers in solid cancers by Lianidou, Evi S., Strati, Areti, Markou, Athina

“…Abstract The presence of circulating tumor cells (CTCs) in peripheral blood can serve as a "liquid biopsy" approach and has thus emerged lately as one of the…”
Get full text

Prognostic Value of Mature MicroRNA-21 and MicroRNA-205 Overexpression in Non-Small Cell Lung Cancer by Quantitative Real-Time RT-PCR by Markou, Athina, Tsaroucha, Emily G, Kaklamanis, Loukas, Fotinou, Marianthi, Georgoulias, Vassilis, Lianidou, Evi S

“…microRNA (miRNA) expression profiles are being intensively investigated for their involvement in carcinogenesis. We evaluated the prognostic value of mature…”
Get full text

Molecular characterization of circulating tumor cells in breast cancer: challenges and promises for individualized cancer treatment by Lianidou, Evi S., Markou, Athina, Strati, Areti

“…Blood testing using Circulating Tumor Cells (CTCs) has emerged as one of the hottest fields in cancer diagnosis. Research on CTCs present nowadays a challenge,…”
Get full text

RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA by Giannopoulou, Lydia, Chebouti, Issam, Pavlakis, Kitty, Kasimir-Bauer, Sabine, Lianidou, Evi S

“…The RASSF1A promoter is frequently methylated in high-grade serous ovarian cancer (HGSC). We examined RASSF1A promoter methylation in primary tumors, adjacent…”
Get full text

ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancer by Giannopoulou, Lydia, Mastoraki, Sophia, Buderath, Paul, Strati, Areti, Pavlakis, Kitty, Kasimir-Bauer, Sabine, Lianidou, Evi S.

“…Estrogen receptor, coded by the ESR1 gene, is highly expressed in epithelial ovarian cancer. ESR1 gene is frequently methylated in many types of gynecological…”
Get full text

Direct comparison of size-dependent versus EpCAM-dependent CTC enrichment at the gene expression and DNA methylation level in head and neck squamous cell carcinoma by Zavridou, Martha, Mastoraki, Sophia, Strati, Areti, Koutsodontis, George, Klinakis, Apostolos, Psyrri, Amanda, Lianidou, Evi

“…We directly compared two different approaches used for Circulating Tumor Cell (CTC) isolation, a size-dependent microfluidic system versus an EpCAM-dependent…”
Get full text